Records containing: Obesity Type 2 Diabetes Mellitus
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-06-25Early GLP-1 Receptor Agonist and SGLT2 Inhibitor Add-On Strategies in Adults With Obesity, Type 2 Diabetes, Cardiovascular-Kidney-Metabolic Syndrome Stage 2-3, and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Target Trial Emulation
-
CLINICAL_TRIALS study record update · 2026-04-27A Phase 2, Randomized, Double-blind, Placebo-controlled, Study of the Safety and Tolerability of Aleniglipron in Adult Participants With Type 2 Diabetes Mellitus Living With Obesity or Overweight
-
CLINICAL_TRIALS study record update · 2026-04-24The Role of Autoantibodies Against G-protein Coupled Receptors in Obesity
-
CLINICAL_TRIALS study record update · 2026-04-13Chinese Registry of Overweight or Obesity, a Multicenter Real-World Registry Study on Clinical Management - CROWN Study
-
CLINICAL_TRIALS study record update · 2026-04-08Dietary Insights and Nutritional Education in Adults on GLP-1 Therapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-27Impact Of Laparoscopic Sleeve Gastrectomy On Obesity-Related Comorbidities In Patients Over 65 Years: A Prospective Comparative Study
-
CLINICAL_TRIALS study record update · 2026-02-19Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy
-
CLINICAL_TRIALS study record update · 2026-02-18Leistung Und Sicherheit Des Trans-Duodenal Barrier (LuST)
-
CLINICAL_TRIALS study record update · 2026-02-10A Phase 2, Randomized, Double-blind, Placebo-controlled, Study of the Safety and Tolerability of Aleniglipron in Adult Participants With Type 2 Diabetes Mellitus Living With Obesity or Overweight
-
CLINICAL_TRIALS study record update · 2026-01-15Development of a Database of Metabolic Cases and Prevalence of Metabolic Liver Dysfunction (MAFLD/MASLD) in Individuals With Metabolic Syndrome Characteristics - Screening Study (ENDOCARE - SCREEN)
-
CLINICAL_TRIALS study record update · 2025-12-16Ensayo Exploratorio Para Evaluar la Tolerancia de Una Bacteria Con Potencial probiótico (Phascolarcobacterium Faecium) de Nueva generación Para Proteger la Salud metabólica en Humanos
-
CLINICAL_TRIALS study record update · 2025-12-03Evaluating the Triglyceride-Glucose Index and TGI-BMI for Insulin Resistance Assessment: A Comparative Study With HOMA-IR
-
CLINICAL_TRIALS study record update · 2025-09-15Evaluation the Effect of Mangosteen Supplement as Adjuvant Therapy With Sitagliptin/Metformin in Type 2 Diabetic Iraqi Patients
-
CLINICAL_TRIALS study record update · 2025-08-27Evaluating Pericoronary Adipose Tissue Attenuation in Glycometabolic Diseases
-
CLINICAL_TRIALS study record update · 2025-08-18Use of Continuous Glucose Monitoring in Veterans With Uncontrolled Diabetes Managed Without Insulin Therapy
-
CLINICAL_TRIALS study record update · 2025-07-11A Phase II Randomized, Double-blind, Multi-center Study to Investigate the Efficacy and Safety of PG-102(MG12) Compared With Placebo in Subjects With Obesity and in Subjects With Type 2 Diabetes Mellitus (T2DM)
-
CLINICAL_TRIALS study record update · 2015-02-13A Phase III Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of Taranabant (MK0364) in Overweight and Obese Patients With Type 2 Diabetes Mellitus (T2DM) Followed by a 1-Year Extension